Vifor Intl Company Profile
✉ Email this page to a colleague
What is the competitive landscape for VIFOR INTL
VIFOR INTL has one approved drug.
There are twelve US patents protecting VIFOR INTL drugs.
There are forty-eight patent family members on VIFOR INTL drugs in twenty-seven countries and fifteen supplementary protection certificates in thirteen countries.
Summary for Vifor Intl
| International Patents: | 48 |
| US Patents: | 12 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Vifor Intl
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vifor Intl | KORSUVA | difelikefalin acetate | SOLUTION;INTRAVENOUS | 214916-001 | Aug 23, 2021 | RX | Yes | Yes | 8,536,131 | ⤷ Try for Free | Y | Y | ⤷ Try for Free | ||
| Vifor Intl | KORSUVA | difelikefalin acetate | SOLUTION;INTRAVENOUS | 214916-001 | Aug 23, 2021 | RX | Yes | Yes | ⤷ Try for Free | ⤷ Try for Free | |||||
| Vifor Intl | KORSUVA | difelikefalin acetate | SOLUTION;INTRAVENOUS | 214916-001 | Aug 23, 2021 | RX | Yes | Yes | 7,727,963 | ⤷ Try for Free | Y | Y | ⤷ Try for Free | ||
| Vifor Intl | KORSUVA | difelikefalin acetate | SOLUTION;INTRAVENOUS | 214916-001 | Aug 23, 2021 | RX | Yes | Yes | 7,402,564 | ⤷ Try for Free | Y | Y | ⤷ Try for Free | ||
| Vifor Intl | KORSUVA | difelikefalin acetate | SOLUTION;INTRAVENOUS | 214916-001 | Aug 23, 2021 | RX | Yes | Yes | 10,138,270 | ⤷ Try for Free | ⤷ Try for Free | ||||
| Vifor Intl | KORSUVA | difelikefalin acetate | SOLUTION;INTRAVENOUS | 214916-001 | Aug 23, 2021 | RX | Yes | Yes | 8,486,894 | ⤷ Try for Free | ⤷ Try for Free | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Vifor Intl Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Korea | 101513736 | ⤷ Try for Free |
| Malaysia | 153678 | ⤷ Try for Free |
| Slovenia | 2064228 | ⤷ Try for Free |
| France | 22C1054 | ⤷ Try for Free |
| South Africa | 200903053 | ⤷ Try for Free |
| Japan | 2010509343 | ⤷ Try for Free |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Vifor Intl Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2064228 | C20220035 00379 | Estonia | ⤷ Try for Free | PRODUCT NAME: DIFELIKEFALIIN;REG NO/DATE: EU/1/22/1643 27.04.2022 |
| 2064228 | PA2022522,C2064228 | Lithuania | ⤷ Try for Free | PRODUCT NAME: DIFELIKEFALINAS, BET KOKIA FORMA, KURIAI TAIKOMA PAGRINDINIO PATENTO APSAUGA ; REGISTRATION NO/DATE: EU/1/22/1643 20220425 |
| 2064228 | 821 | Finland | ⤷ Try for Free | |
| 2064228 | 22C1054 | France | ⤷ Try for Free | PRODUCT NAME: DIFELIKEFALINE DANS TOUTES LES FORMES PROTEGEES PAR LE BREVET DE BASE; REGISTRATION NO/DATE: EU/1/22/1643 20220427 |
| 2064228 | C202230052 | Spain | ⤷ Try for Free | PRODUCT NAME: DIFELICEFALINA, OPCIONALMENTE EN FORMA DE UNA SAL FARMACEUTICAMENTE ACEPTABLE,HIDRATO, SOLVATO, HIDRATO DE SAL DE ACIDO O N-OXIDO; NATIONAL AUTHORISATION NUMBER: EU/1/22/1643; DATE OF AUTHORISATION: 20220425; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/22/1643; DATE OF FIRST AUTHORISATION IN EEA: 20220425 |
| 2064228 | CA 2022 00045 | Denmark | ⤷ Try for Free | PRODUCT NAME: DIFELIKEFALIN IN ALL FORMS COVERED BY THE BASIC PATENT; REG. NO/DATE: EU/1/22/1643 20220427 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
